Medication Non-Adherence in Diabetes: A Look at Costs
Oral medications and insulin are cornerstones of diabetes management, but as many as one-third of...
Nov 14, 2013
Oral medications and insulin are cornerstones of diabetes management, but as many as one-third of...
Nov 6, 2013
Published research has indicated that people with type 2 diabetes are at increased risk for bone...
Aug 19, 2013
Studies suggest that group-based diabetes education efforts can improve short- and long-term...
Feb 14, 2013
This Physician’s Weekly feature on managing cognitive decline in older adults with diabetes was completed in cooperation with the experts at the American Diabetes Association. More than 25% of Americans aged 65 and older has...
Nov 29, 2012
Tight glycemic control appears to be achievable following cardiac surgery in children ages 0 to 36 months, with low rates of hypoglycemia, according to a randomized, control trial. The researchers noted, however, that tight...
Nov 27, 2012
To successfully manage type 2 diabetes in older adults, clinicians must recognize and understand the unique challenges these individuals face. While the benefits of tight glycemic control in older adults are similar to those of...
Nov 27, 2012
This Physician’s Weekly feature covering the transitioning from pediatric to adult diabetes care was completed in cooperation with the experts at the American Diabetes Association. During childhood and adolescence, diabetes care...
Nov 19, 2012
[sam id=”4″ codes=”true”]In recent years, more pharmacologic agents and...
Oct 16, 2012
Approximately 45% of patients with diabetes have not achieved an A1C level of less than 7%. Studies show that improved glycemia helps delay or prevent serious diabetes complications. However, poor adherence to medication...
May 22, 2012
In the United States, diabetes affects 25.8 million people, for whom the costs of care exceed $100 billion annually. Clinical trials suggest that improved self-care and lifestyle changes can lead to better diabetes-related...
Apr 16, 2012
Exenatide extended-release for injectable suspension (Bydureon, Amylin) has been approved by the FDA as a once-weekly treatment for type 2 diabetes. The glucagon-like peptide-1 receptor agonist is indicated as an adjunct to diet...
Nov 9, 2011
This Physician’s Weekly feature was completed in cooperation with the experts at the American Diabetes Association. Over the last decade, healthcare providers in primary care settings and endocrinology practices have seen...